Company Search:
Advanced Search
Sponsored Links
Falco Holdings Co Ltd Company Snapshot
Falco Holdings Co Ltd operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other pharmaceutical manufacturers in Asia: Medical & Biological Laboratories Company Limited (2017 sales of 7.35 billion Japanese Yen [US$68.93 million] of which 99% was Reagent business), Thyrocare Technologies Ltd of India (3.07 billion Indian Rupees [US$47.31 million] of which 89% was Diagnostic Testing Services), and Dr. Lal PathLabs Ltd which is also based in India (9.12 billion Indian Rupees [US$140.69 million] of which 100% was Healthcare).

Sales Analysis. Falco Holdings Co Ltd reported sales of ¥45.97 billion (US$431.21 million) for the fiscal year ending March of 2017. This represents a decrease of 5.7% versus 2016, when the company's sales were ¥48.73 billion. Contributing to the drop in overall sales was the 9.8% decline in Preparation of Drugs, from ¥20.09 billion to ¥18.12 billion. There were also decreases in sales in Medical Test (down 2.8% to ¥27.85 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Falco Holdings Co Ltd
  Stock Performance Chart for Falco Holdings Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 1,791.00
(Figures in Japanese Yen)
1 Week 3.8%   13 Weeks 5.9%  
4 Weeks 3.8%   52 Weeks 15.8%  
Falco Holdings Co Ltd Key Data:
  Ticker: 4671 Country: Japan
  Exchanges: TYO Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2017 Sales 45,971,000,000
(Year Ending Jan 2018).
Employees: 1,402
  Currency: Japanese Yen Market Cap: 19,492,909,083
  Fiscal Yr Ends: March Shares Outstanding: 10,883,813
  Share Type: Common Closely Held Shares: 2,449,560
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.